Jinhan Kim

Pharma to AI pharma. CEO/Co-founder @standigm, the workflow AI drug discovery company. Previous researcher @Samsung, PhD AI @InfAtEd, SW developer @NCSOFT

[Standigm @standigm]

Standigm will present our recent #AI drug discovery papers at the #MLDD Workshop (#ICLR2022).
✔️ #GRPE: Relative Positional Encoding for Graph Transformer
https://t.co/kZ81N2uhAK
✔️#MetaDTA: Meta-learning-based #drug-target binding affinity prediction
https://t.co/AIBYQJRYOm

[Standigm @standigm]

✉️We want to invite YOU to our first official company #newsletter, which will be published on Thursday this week. Don't miss out on all the latest news from Standigm: subscribe to our newsletter! It only takes a few simple clicks: https://t.co/you1xPGecL
#AIdrugdiscovery #AI #bio

[Standigm @standigm]

🌍#Standigm is going to participate in various #healthcare #events around the world in 1H 2022.
Feel free to visit and contact us and explore the future of #AI #drugdiscovery and our other cutting-edge technologies and AI-driven #drug pipelines.

[Standigm @standigm]

Do you remember that we have opened the Standigm Synthesis Research Center at the end of last year? Yesterday, the center conducted the first #synthesis experiment, to synthesize derivatives of Standigm’s in-house #AI-driven #cancer #pipeline.

[Jinhan Kim @JinhanKim_AI]

New and great work on epitope prediction from my Sabre Bio Lab.
https://t.co/F0HsWvv1pb

[Günter Klambauer @gklambauer]

Generating biological sequences with gflow-nets. Similar goals as for small molecules: maximize diversity, novelty and "activity". https://t.co/YjvBh31m6P

[Standigm @standigm]

Today, the vice minister of the Ministry of Science and ICT (#MIST) visited the Standigm Seoul office to see how the company's #AI platform works and discuss the future aids from the government to accelerate the AI #drugdiscovery.
📰 Related article: https://t.co/oMReflFwcC

[yobibyte @y0b1byte]

PhD student and his advisor...

[Standigm @standigm]

🔬 Pleased to announce the opening of our new Antibody Research Lab.

Standigm’s research capabilities continue to grow. Keep watching for Standigm’s footprints in the AI drug discovery!

#Standigm #WorkflowAI #Aidrugdiscovery #artificialintelligence #AI #drugdiscovery #Antibody

[Markus Wulfmeier @m_wulfmeier]

Great news for transfer in RL/ML!

As the field matures, machine learning conferences explode and our workshops grow bigger, new targeted conferences have a big role to play to help accelerating progress and streamlining comms.

[CoLLAs 2026 @CoLLAs_Conf]

Our aim is to bring together researchers working on ML paradigms like lifelong/continual learning, meta-learning, multi-task learning, transfer-learning, OOD generalization that aim to design systems that can generalize to many tasks and distributions. 2/

[Julia Chatterley @chattwithjulia]

“Ultimately, all drugs will be designed using #AI.”

@exscientiaAI CEO Andrew Hopkins says the #pharmatech's AI-first approach will be used to find more efficient drugs to tackle future pandemics, cancer, Alzheimer’s & more - and faster! 🙌

@firstmove | $EXAI | #biotech

[CoLLAs 2026 @CoLLAs_Conf]

We are thrilled to announce a new focused #MachineLearning conference: International Conference on Lifelong Learning Agents (CoLLA) https://t.co/ueLgjFzrTR 1/

[Standigm @standigm]

Standigm is listed as "Top 33 Leading #AI #DrugDiscovery Companies in Expertise in Drug Discovery R&D" in the @DeepPharmaUK report.

Full Report: https://t.co/s0XamUQgxj #WorkflowAI #Aidrugdiscovery

#Standigm #WorkflowAI #Aidrugdiscovery #ArtificialIntelligence

[Jinhan Kim @JinhanKim_AI]

@BigHatBio Great company, you are

[Standigm @standigm]

Recently, we have received two more fundings to expand our AI drug development capacity and accelerate global competitiveness.
This brings the total amount of capital raised to date to over $70 million.

Read more:
https://t.co/nJQUFmaDvk
https://t.co/CGAPQv0anB

[Standigm @standigm]

#Standigm recently invited @minkbaek (Ph.D. at Washington Univ.), who led the development of RoseTTAFold, to learn about the overview and development process of #RoseTTAFold.

Head over to the link below to know about RoseTTAFold: https://t.co/EpvkRGCo6d

[Standigm @standigm]

📺#Standigm was featured in YTN Science a channel that focuses on the fields of science and technology run by the YTN and Ministry of Science and ICT.

Full video available here : https://t.co/tLqVpatiNP

#AIdrugdiscovery #drugdiscovery #AI

[Standigm @standigm]

🦾 Cool and inspiring #Standigm to be highlighted as one of 5 top #AI #startups in #drugdiscovery.

“The startup’s solutions eliminate the uncertainty in the drug discovery process to save time and costs during development.” - StartUs Insights
👉Read more: https://t.co/WyxIQNKmAN

[BioIndustry Association (BIA) @BIA_UK]

Welcome to new BIA members @standigm 🎉

Standigm is a drug discovery company that searches for therapeutic lead compounds using advanced artificial intelligence (AI) methods trained on big biomedical data.

Learn more👇
https://t.co/wwtSfxOzAf